The median overall survival estimate from the time of diagnosis was 152.6 months (95% CI [123.8–181.5]) for the entire cohort and differed significantly between IDH mutant astrocytomas and oligodendrogliomas, IDH mutant and 1p19q deleted (respectively 115.2 and 176.1 months, p = 0.002, log-rank test). Here, IDH1 is linked to astrocytoma (excluding glioblastoma).